Holidays Complicate Diabetes Management, Patients Report
Nearly half of US adults living with type 2 diabetes say managing their condition is more difficult during the fall and winter holiday season than other times of the year.
Diabetes
COVID-19 Vaccine Does Not Affect Glycemic Control in People With Diabetes
The COVID-19 vaccine is particularly recommended for people with chronic conditions like type 1 and type 2 diabetes. Researchers sought to find out if the vaccine caused a change in glycemic control.
Bariatric Surgery Cuts Hepatic Steatosis in Obesity and T2DM
Similar decline in liver fat fraction seen for sleeve gastrectomy, Roux-en-Y gastric bypass from surgery to one-year follow-up.
Access to Care Disrupted for Young Adults With Diabetes in COVID
Young adults with diabetes also report lower intention of receiving COVID-19 vaccination compared with those 60 years or older.
Unique Risks in People With Familial Hypercholesterolemia and COVID-19
People with familial hypercholesterolemia with COVID-19 risk endothelial dysfunction. Therapy should continue during the course of the virus.
Early Treatment With Sotrovimab Decreases Risk for Progression to Severe COVID-19
Researchers conducted a study to determine whether treatment with sotrovimab decreases the risk for severe disease progression among high-risk patients with mild-to-moderate COVID-19.
Veterans With High Blood Glucose, Insulin Use, Risk COVID-19 Complications
People with diabetes are at a higher risk of experiencing poor outcomes after contracting COVID-19, including hospitalization and death. Researchers expanded on a previous analysis to identify risk factors for short-term adverse outcomes among veterans with diabetes and COVID-19.
Racial, Ethnic Disparities in COVID-19 Testing and Outcomes
Researchers conducted a study to determine the effect of patient characteristics and racial/ethnic disparities on outcomes of SARS-CoV-2 infection.
COVID-19 Vaccine Immune Response in the Dialysis Population Quantified
A recent meta-analysis demonstrated that patients on dialysis are less likely to produce an immune response than those not on dialysis.
Do At-Home Monoclonal Antibody Infusions Decrease the Risk for Hospitalization in High-Risk Patients With COVID-19?
Researchers conducted a study to assess whether an at-home neutralizing monoclonal antibody infusion program decreases the risk for hospitalization among patients with SARS-CoV-2 infection at increased risk for progression to severe disease.
- Loading...
Loading...
Next post in COVID19
Loading... 
Loading...